October 14, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against UNCY

Core Viewpoint - A class action securities lawsuit has been filed against Unicycive Therapeutics, Inc. due to alleged securities fraud affecting investors between March 29, 2024, and June 27, 2025 [1][2]. Group 1: Lawsuit Details - The lawsuit claims that Unicycive Therapeutics made false statements regarding its ability to meet FDA manufacturing compliance requirements, overstating its readiness [3]. - It is alleged that the regulatory prospects of the oxylanthanum carbonate new drug application were also overstated, leading to materially false and misleading public statements [3]. Group 2: Investor Information - Investors who suffered losses during the specified timeframe have until October 14, 2025, to request to be appointed as lead plaintiff, although participation does not require this [4]. - Class members may be entitled to compensation without any out-of-pocket costs or fees [4]. Group 3: Legal Firm Background - Levi & Korsinsky, LLP has a history of securing hundreds of millions of dollars for shareholders and is recognized as one of the top securities litigation firms in the United States [5].